Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,900 | 277 | 97.8% |
| Education | $112.31 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $874.01 | 51 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $868.67 | 30 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $757.18 | 39 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $457.55 | 43 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $407.03 | 29 | $0 (2020) |
| Alkermes, Inc. | $395.44 | 15 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $301.82 | 16 | $0 (2024) |
| ABBVIE INC. | $255.44 | 17 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $233.94 | 14 | $0 (2020) |
| Lundbeck LLC | $209.32 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.50 | 1 | Teva Pharmaceuticals USA, Inc. ($105.50) |
| 2023 | $53.18 | 3 | ABBVIE INC. ($53.18) |
| 2022 | $103.48 | 6 | ABBVIE INC. ($85.01) |
| 2021 | $117.25 | 9 | AbbVie Inc. ($117.25) |
| 2020 | $459.32 | 24 | Allergan, Inc. ($239.92) |
| 2019 | $1,116 | 72 | Otsuka America Pharmaceutical, Inc. ($244.28) |
| 2018 | $1,735 | 92 | Sunovion Pharmaceuticals Inc. ($418.31) |
| 2017 | $1,322 | 72 | Sunovion Pharmaceuticals Inc. ($338.87) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $105.50 | General |
| 05/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $18.47 | General |
| 07/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2020 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: OBESITY | ||||||
| 10/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 54 | 155 | $27,125 | $4,483 |
| 2022 | 1 | 80 | 219 | $38,325 | $7,675 |
| 2021 | 1 | 118 | 300 | $52,500 | $10,101 |
| 2020 | 4 | 322 | 447 | $76,800 | $11,022 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 155 | $27,125 | $4,483 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 219 | $38,325 | $7,675 | 20.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 300 | $52,500 | $10,101 | 19.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 268 | $46,900 | $8,527 | 18.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 40 | 42 | $7,350 | $822.67 | 11.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 16 | $4,400 | $810.63 | 18.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 66 | 70 | $10,500 | $506.25 | 4.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 15 | $2,250 | $183.78 | 8.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 36 | 36 | $5,400 | $171.67 | 3.2% |
About Dr. Sujatha Reddy, M.D
Dr. Sujatha Reddy, M.D is a Psychiatry healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053408328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sujatha Reddy, M.D has received a total of $5,012 in payments from pharmaceutical and medical device companies, with $105.50 received in 2024. These payments were reported across 279 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,900).
As a Medicare-enrolled provider, Reddy has provided services to 574 Medicare beneficiaries, totaling 1,121 services with total Medicare billing of $33,281. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Macon, GA
- Active Since 10/06/2006
- Last Updated 05/11/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1053408328
Products in Payments
- VRAYLAR (Drug) $1,129
- LATUDA (Drug) $757.18
- REXULTI (Drug) $577.26
- INGREZZA (Drug) $457.55
- ABILIFY MAINTENA (Drug) $399.29
- INVEGA SUSTENNA (Drug) $378.38
- Aristada 441 mg (Drug) $341.15
- AUSTEDO (Drug) $174.25
- NUEDEXTA (Drug) $146.35
- Fanapt (Drug) $100.15
- Hetlioz (Drug) $85.87
- ARISTADA (Drug) $54.29
- FANAPT (Drug) $47.92
- INVEGA TRINZA (Drug) $28.65
- SD809-TD (Drug) $22.07
- APLENZIN (Drug) $20.43
- CitraNatal (Drug) $19.92
- CONTRAVE (Drug) $14.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Macon
Dr. Ronnie Blount, M.d, M.D
Psychiatry — Payments: $87,626
Angela Eubanks, Msn, Pmhnp-Bc, MSN, PMHNP-BC
Psychiatry — Payments: $29,052
Angela Hale, M.d, M.D
Psychiatry — Payments: $5,768
Dr. Sarah Graff, Md, MD
Psychiatry — Payments: $3,311
Jacob Hanna, Md, MD
Psychiatry — Payments: $1,544
Dwight Bearden, Md, MD
Psychiatry — Payments: $1,292